DK149942C - Fremgangsmaade til fremstilling af en pasteurellose-vaccine - Google Patents

Fremgangsmaade til fremstilling af en pasteurellose-vaccine

Info

Publication number
DK149942C
DK149942C DK176480A DK176480A DK149942C DK 149942 C DK149942 C DK 149942C DK 176480 A DK176480 A DK 176480A DK 176480 A DK176480 A DK 176480A DK 149942 C DK149942 C DK 149942C
Authority
DK
Denmark
Prior art keywords
pasteurellose
vaccine
preparing
procedure
pasteurellose vaccine
Prior art date
Application number
DK176480A
Other languages
English (en)
Other versions
DK176480A (da
DK149942B (da
Inventor
Neil James Livingston Gilmour
William Barr Martin
James Michael Sharp
Dannis Arthur Thompson
Peter William Wells
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of DK176480A publication Critical patent/DK176480A/da
Publication of DK149942B publication Critical patent/DK149942B/da
Application granted granted Critical
Publication of DK149942C publication Critical patent/DK149942C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/823—Bacterial vaccine for bovine species, e.g. cattle
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/824—Bacterial vaccine for ovine species, e.g. sheep

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Adhesives Or Adhesive Processes (AREA)
DK176480A 1978-08-24 1980-04-24 Fremgangsmaade til fremstilling af en pasteurellose-vaccine DK149942C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB7834525 1978-08-24
GB7834525 1978-08-24
GB7900141 1979-08-16
PCT/GB1979/000141 WO1980000412A1 (en) 1978-08-24 1979-08-16 Pasteurellosis vaccines

Publications (3)

Publication Number Publication Date
DK176480A DK176480A (da) 1980-04-24
DK149942B DK149942B (da) 1986-11-03
DK149942C true DK149942C (da) 1987-05-04

Family

ID=10499258

Family Applications (1)

Application Number Title Priority Date Filing Date
DK176480A DK149942C (da) 1978-08-24 1980-04-24 Fremgangsmaade til fremstilling af en pasteurellose-vaccine

Country Status (12)

Country Link
US (1) US4346074A (da)
EP (1) EP0020356B1 (da)
AU (1) AU528776B2 (da)
BE (1) BE878430A (da)
CA (1) CA1133829A (da)
DE (1) DE2964721D1 (da)
DK (1) DK149942C (da)
IE (1) IE48402B1 (da)
NO (1) NO151225C (da)
NZ (1) NZ191327A (da)
WO (1) WO1980000412A1 (da)
ZA (1) ZA794416B (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328210A (en) 1980-03-31 1982-05-04 Norden Laboratories, Inc. Modified Pasteurella bacteria and vaccines prepared therefrom
US4293545A (en) 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
US4335106A (en) 1980-03-31 1982-06-15 Norden Laboratories Inc. Processes for the growth of a modified Pasteurella multocida bacteria and preparation of a vaccine therefrom
US4506017A (en) * 1981-04-17 1985-03-19 Norden Laboratories, Inc. Modified Pasteurella haemolytica bacteria
US4559306A (en) * 1981-04-17 1985-12-17 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria
US4626430A (en) * 1981-04-17 1986-12-02 Norden Laboratories, Inc. Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom
JPS62162963A (ja) * 1986-01-10 1987-07-18 Sadao Shiosaka 金属コロイド粒子を担体とする低分子物質に対する特異抗体の作成法
US5165924A (en) * 1986-01-22 1992-11-24 University Of Guelph Serum-free, cell-free vaccine effective against pneumonic pasteurellosis in cattle
ES2059503T5 (es) * 1987-03-24 2000-01-16 Btg International Limited Comp Procedimiento para preparar una vacuna contra pasteurella.
US5256415A (en) * 1989-03-20 1993-10-26 Louisiana State University Vaccine against bovine respiratory disease (pasteurellosis)
US5273889A (en) * 1990-08-22 1993-12-28 University Of Saskatchewan Gamma-iterferon-leukotoxin gene fusions and uses thereof
US5594107A (en) * 1990-08-22 1997-01-14 University Of Saskatchewan Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon
US5238823A (en) * 1990-08-22 1993-08-24 Veterinary Infectious Disease Organization Interleukin-2-leukotoxin gene fusions and uses thereof
MX9301736A (es) * 1992-03-30 1994-01-31 Smithkline Beecham Corp Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1.
US5855894A (en) * 1992-03-30 1999-01-05 Pfizer Inc. Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
FR2689520B1 (fr) 1992-04-03 1996-07-19 Bio Merieux Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques.
FR2689521B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture.
US5534256A (en) * 1992-07-02 1996-07-09 University Of Saskatchewan Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US6793927B1 (en) * 1993-12-06 2004-09-21 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Construction of Pasteurella haemolytica vaccines
US5587305A (en) * 1993-12-06 1996-12-24 The United States Of America As Represented By The Department Of Agriculture Pasteurella haemolytica transformants
AU704440B2 (en) * 1994-02-04 1999-04-22 Bio Merieux MSRV1 virus and MSRV2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same
FR2716198B1 (fr) * 1994-02-15 1996-04-19 Bio Merieux Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
US20010055581A1 (en) * 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
FR2737500B1 (fr) 1995-08-03 1997-08-29 Bio Merieux Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques
US6355255B1 (en) * 1998-12-07 2002-03-12 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
WO1998023755A1 (en) 1996-11-26 1998-06-04 Bio Merieux Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
FR2760640B1 (fr) * 1997-03-17 1999-05-28 Vetoquinol Sa Utilisation d'une souche de pasteurella haemolytica serotype a6 pour la preparation d'un vaccin contre la pasteurellose bovine due a pasteurella haemolytica
US6407218B1 (en) 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
US7229841B2 (en) * 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US20070077256A1 (en) 1999-11-19 2007-04-05 Los Angeles Biomedical Research Institute Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
US8541008B2 (en) * 1999-11-19 2013-09-24 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Pharmaceutical compositions and methods to vaccinate against candidiasis
WO2005065121A2 (en) * 2003-12-02 2005-07-21 Cytimmune Sciences, Inc. Methods and compositions for the production of monoclonal antibodies
CA2554755A1 (en) * 2004-01-28 2005-08-11 Cytimmune Sciences, Inc. Functionalized colloidal metal compositions and methods
RU2310473C1 (ru) * 2006-06-07 2007-11-20 Открытое Акционерное Общество "Институт Биотехнологий Ветеринарной Медицины" Способ получения вакцины против пастереллеза животных
RU2311199C1 (ru) * 2006-07-06 2007-11-27 Открытое Акционерное Общество "Институт Биотехнологий Ветеринарной Медицины" Вакцина против пастереллеза животных
CA2700378A1 (en) * 2007-09-21 2009-03-29 Cytimmune Sciences, Inc. Nanotherapeutic colloidal metal compositions and methods
US20110014118A1 (en) * 2007-09-21 2011-01-20 Lawrence Tamarkin Nanotherapeutic colloidal metal compositions and methods
EP2219458B1 (en) * 2007-11-08 2015-07-15 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies
NZ592368A (en) 2008-11-05 2013-11-29 Wyeth Llc Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease
RU2414929C1 (ru) * 2009-12-14 2011-03-27 Открытое Акционерное Общество "Институт Биотехнологий Ветеринарной Медицины" Вакцина против пастереллеза животных
AU2012287513A1 (en) 2011-07-22 2014-03-13 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Methods and compositions for vaccinating against Staphylococcus aureus
AU2014227748B2 (en) 2013-03-15 2019-02-14 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for treating fungal and bacterial pathogens
JP2019507759A (ja) 2016-03-09 2019-03-22 ロサンゼルス バイオメディカル リサーチ インスティテュート アット ハーバー− ユーシーエルエー メディカル センター 外陰部膣カンジダ症の予防及び治療で使用するための方法及びキット

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1201052A (en) * 1967-09-07 1970-08-05 Lilly Co Eli Vaccines
US3526696A (en) * 1968-02-14 1970-09-01 Lilly Co Eli Shipping fever vaccine
GB1441098A (en) * 1972-03-29 1976-06-30 Wellcome Found Biological preparations
FR2360314A2 (fr) * 1976-08-06 1978-03-03 Fabre Sa Pierre Nouveaux vaccins perfectionnes a base de fractions ribosomales

Also Published As

Publication number Publication date
IE48402B1 (en) 1985-01-09
US4346074A (en) 1982-08-24
WO1980000412A1 (en) 1980-03-20
NZ191327A (en) 1981-07-13
NO151225B (no) 1984-11-26
IE791618L (en) 1980-02-24
AU5021479A (en) 1980-02-28
BE878430A (fr) 1979-12-17
CA1133829A (en) 1982-10-19
EP0020356A1 (en) 1981-01-07
AU528776B2 (en) 1983-05-12
DK176480A (da) 1980-04-24
ZA794416B (en) 1981-02-25
DK149942B (da) 1986-11-03
NO151225C (no) 1985-03-06
DE2964721D1 (en) 1983-03-17
EP0020356B1 (en) 1983-02-09
NO792748L (no) 1980-02-26

Similar Documents

Publication Publication Date Title
DK149942C (da) Fremgangsmaade til fremstilling af en pasteurellose-vaccine
DK363179A (da) Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
DK457779A (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater
DK149023C (da) Analogifremgangsmaade til fremstilling af tiazolidinderivater
DK364579A (da) Fremgangsmaade til fremstilling af n2-arylsulfonyl-l-arginiamider
DK19579A (da) Fremgangsmaade til fremstilling af spirothienohydantoinderivater
DK7579A (da) Fremgangsmaade til fremstilling af (%n-diethylmeta-toluamid
DK488379A (da) Fremgangsmaade til fremstilling af polyetherderivater
DK54879A (da) Fremgangsmaade til fremstilling af pyrimidoner
DK160767C (da) Fremgangsmaade til fremstilling af en vandig ionisk polyurethandispersion
DK56379A (da) Fremgangsmaade til fremstilling af et pyrrolidinderivat
DK520580A (da) Fremgangsmaade til fremstilling af en pakning
DK320278A (da) N fremgangsmaade til fremstilling af en ensartet fiberdispertio
DK152138C (da) Fremgangsmaade til fremstilling af urokinase
DK225979A (da) Fremgangsmaade til fremstilling af inulaekstrakt
DK138879A (da) Fremgangsmaade til fremstilling af lysergolderivater
DK7679A (da) Fremgangsmaade til fremstilling af et prostaglandinholdigt praeparat
DK150479C (da) Fremgangsmaade til fremstilling af 2-chlor-5-trifluormethylpyridin
DK151383C (da) Fremgangsmaade til fremstilling af et farvestofpraeparat
DK165687C (da) Fremgangsmaade til fremstilling af 2-chlorsulfinylazetidinoner
DK149192C (da) Fremgangsmaade til fremstilling af et stabilt cisplatin-praeparat
DK235379A (da) Fremgangsmaade til fremstilling af et polysaccharid
DK169378A (da) Fremgangsmaade til fremstilling af en oploesning
DK330279A (da) Fremgangsmaade til fremstilling af soem
DK310079A (da) Fremgangsmaade til fremstilling af et cephalosporinpraeparat til rektal indgivning

Legal Events

Date Code Title Description
PBP Patent lapsed